Clinical and immunological effect of subcutaneous immunotherapy in allergic asthma

Conclusion SCIT is a safe treatment strategy that significantly reduce exacerbation and medication requirement in allergic asthma without mixed allergy also improve immunological response.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research